| Stereochemistry | ABSOLUTE |
| Molecular Formula | C26H36F2O6 |
| Molecular Weight | 482.5572 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)COC3=C(F)C=CC(F)=C3)[C@@]1([H])CC[C@H](CCCC(=O)OC(C)C)CO2
InChI
InChIKey=BKVUSNOUTQMSBE-XCMGCKIWSA-N
InChI=1S/C26H36F2O6/c1-16(2)34-26(31)5-3-4-17-6-9-21-20(23(30)13-24(21)32-14-17)10-8-19(29)15-33-25-12-18(27)7-11-22(25)28/h7-8,10-12,16-17,19-21,23-24,29-30H,3-6,9,13-15H2,1-2H3/b10-8+/t17-,19+,20+,21+,23+,24-/m0/s1
| Molecular Formula | C26H36F2O6 |
| Molecular Weight | 482.5572 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
Approval Year
|
|
TARGET->WEAK AGONIST |
EC50
3030 (average) |
||
|
|
TARGET->WEAK AGONIST |
Prodrug becomes agonist upon cleavage
[>10000] NANOMOLAR (average) |
Showing 1 to 2 of 2 entries
